163 related articles for article (PubMed ID: 28706119)
1. Disparities and Trends in Door-to-Needle Time: The FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).
Oluwole SA; Wang K; Dong C; Ciliberti-Vargas MA; Gutierrez CM; Yi L; Romano JG; Perez E; Tyson BA; Ayodele M; Asdaghi N; Gardener H; Rose DZ; Garcia EJ; Zevallos JC; Foster D; Robichaux M; Waddy SP; Sacco RL; Rundek T;
Stroke; 2017 Aug; 48(8):2192-2197. PubMed ID: 28706119
[TBL] [Abstract][Full Text] [Related]
2. Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).
Asdaghi N; Romano JG; Wang K; Ciliberti-Vargas MA; Koch S; Gardener H; Dong C; Rose DZ; Waddy SP; Robichaux M; Garcia EJ; Gonzalez-Sanchez JA; Burgin WS; Sacco RL; Rundek T
Stroke; 2016 Oct; 47(10):2618-26. PubMed ID: 27553032
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Impact of Implementation of a Stroke Protocol on Door-to-Needle Time in the Administration of Intravenous Tissue Plasminogen Activator.
Hillen ME; He W; Al-Qudah Z; Wang W; Hidalgo A; Walia J
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1569-1572. PubMed ID: 28411038
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.
Asdaghi N; Wang K; Ciliberti-Vargas MA; Gutierrez CM; Koch S; Gardener H; Dong C; Rose DZ; Garcia EJ; Burgin WS; Zevallos JC; Rundek T; Sacco RL; Romano JG;
Stroke; 2018 Mar; 49(3):638-645. PubMed ID: 29459397
[TBL] [Abstract][Full Text] [Related]
5. Stroke Hospital Characteristics in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.
Ciliberti-Vargas MA; Gardener H; Wang K; Dong C; Yi L; Romano JG; Robichaux M; Waddy SP; Nobo U; Diaz-Acosta S; Rundek T; Waters MF; Sacco RL
South Med J; 2017 Jul; 110(7):466-474. PubMed ID: 28679016
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic Disparities in Mortality Among Medicare Beneficiaries in the FL - PR CR eSD Study.
Gardener H; Leifheit EC; Lichtman JH; Wang Y; Wang K; Gutierrez CM; Ciliberti-Vargas MA; Dong C; Oluwole S; Robichaux M; Romano JG; Rundek T; Sacco RL;
J Am Heart Assoc; 2019 Jan; 8(1):e009649. PubMed ID: 30587062
[TBL] [Abstract][Full Text] [Related]
7. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
[TBL] [Abstract][Full Text] [Related]
8. Sex and Race-Ethnic Disparities in Door-to-CT Time in Acute Ischemic Stroke: The Florida Stroke Registry.
Polineni SP; Perez EJ; Wang K; Gutierrez CM; Walker J; Foster D; Dong C; Asdaghi N; Romano JG; Sacco RL; Rundek T;
J Am Heart Assoc; 2021 Apr; 10(7):e017543. PubMed ID: 33787282
[TBL] [Abstract][Full Text] [Related]
9. Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.
Sacco RL; Gardener H; Wang K; Dong C; Ciliberti-Vargas MA; Gutierrez CM; Asdaghi N; Burgin WS; Carrasquillo O; Garcia-Rivera EJ; Nobo U; Oluwole S; Rose DZ; Waters MF; Zevallos JC; Robichaux M; Waddy SP; Romano JG; Rundek T;
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28196814
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.
Aparicio HJ; Carr BG; Kasner SE; Kallan MJ; Albright KC; Kleindorfer DO; Mullen MT
J Am Heart Assoc; 2015 Oct; 4(10):e001877. PubMed ID: 26467999
[TBL] [Abstract][Full Text] [Related]
12. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
[TBL] [Abstract][Full Text] [Related]
13. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
14. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
[TBL] [Abstract][Full Text] [Related]
15. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
[TBL] [Abstract][Full Text] [Related]
16. Disparities in the Use of Intravenous t-PA among Ischemic Stroke Patients: Population-based Recent Temporal Trends.
Faysel MA; Singer J; Cummings C; Stefanov DG; Levine SR
J Stroke Cerebrovasc Dis; 2019 May; 28(5):1243-1251. PubMed ID: 30745230
[TBL] [Abstract][Full Text] [Related]
17. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
18. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
Sauser K; Levine DA; Nickles AV; Reeves MJ
JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
[TBL] [Abstract][Full Text] [Related]
19. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study.
Hsia AW; Edwards DF; Morgenstern LB; Wing JJ; Brown NC; Coles R; Loftin S; Wein A; Koslosky SS; Fatima S; Sánchez BN; Fokar A; Gibbons MC; Shara N; Jayam-Trouth A; Kidwell CS
Stroke; 2011 Aug; 42(8):2217-21. PubMed ID: 21719765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
